Changing Treatment Paradigms and Unmet Needs in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Metastatic Breast Cancer (mBC): Results from Health Records Data
Real-World Treatment Patterns and Clinical Outcomes for Patients with Metastatic Triple-Negative Breast Cancer (mTNBC) in the United States: an Electronic Health Records Observational Study
Evolving Treatment Paradigms and Unmet Needs in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2-), PIK3CA-Mutated Metastatic Breast Cancer (mBC): Results from Real-World U.S. Health Records Data
Real-World Clinical Practice PIK3CA Biomarker Testing Patterns in Patients with Hormone Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2–Negative (HER2-) Metastatic Breast Cancer (mBC)
Use of Natural Language Processing to Identify Myeloid/Lymphoid Neoplasm Patients with Fibroblast Growth Factor Receptor 1 Alterations
Longer use of Amikacin Liposomal Inhalation Suspension During First 12 Months Associated with Lower Risk of Hospitalizations and Emergency Room Visits: A Claims Analysis
Severe Exacerbations in Patients Following Improved Adherence to Inhaled Corticosteroid-Containing Asthma Maintenance Medications Versus Not: A US Claim-Based Study
Impact Of Timing Of Nontuberculous Mycobacterial Lung Disease Antibiotic Initiation On Hospitalizations And Outpatient Visits In Japan
A Retrospective Real-World Evaluation of Docetaxel-Based Treatments After Standard of Care (SOC) for Patients with Nonsquamous (NSQ) Advanced Non-Small Cell Lung Cancer (aNSCLC)
Longer Use of Amikacin Liposomal Inhalation Suspension During First 12 Months Associated with Lower Risk of Hospitalizations and Emergency Room Visits: A Claims Analysis
